Iran unveils two new radio medicines
Salehi made the inaugurations during a tour of an exhibition of technological and research achievements of the Research Center for Nuclear Science and Technology.
The new radio medicines, LU177-Rituximab and LU177-Trastuzumab, have been designed for cancer treatment.
Both radio medicines have successfully undergone the clinical tests at nuclear medicine unit of Bushehr University of medical Sciences.
